A randomized controlled trial of estrogen treatment in men with mild cognitive impairment

Neurobiology of Aging

Volumn 32, Issue 10, 2011, Pages 1808-1817

  Sherwin, Barbara B ^a   Chertkow, Howard ^b,c   Schipper, Hyman ^b,c   Nasreddine, Ziad ^d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Elderly men; Estrogen; Mild cognitive impairment; Randomized controlled trial; Testosterone; Verbal memory

Indexed keywords

ESTRADIOL; PLACEBO;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE; VERBAL MEMORY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ATTENTION; COGNITION DISORDERS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGENS; EXECUTIVE FUNCTION; HORMONES; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; SPACE PERCEPTION; TREATMENT OUTCOME;

EID: 80051570913     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.11.002     Document Type: Article

References (35)

1. Buschke H. Selective reminding for analysis of memory and learning. J. Verb. Learning Verb. Behav. 1973, 12:543-550.
2. Chen S., Nilsen J., Brinton R.D. Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. Endocrinology 2006, 147:5303-5313.
3. Cherrier M.M., Asthana S., Plymate S., Baker L., Matsumoto A.M., Peskind E., Raskind M.A., Brodkin K., Bremner W., Petrova A., LaTendresse S., Craft S. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology 2001, 57:80-88.
4. Cherrier M.M., Matsumoto A.M., Amory J.K., et al. The role of aromatization in testosterone supplementation - effects on cognition in older men. Neurology 2005, 64:290-296.
5. Compendium of Pharmaceuticals and Specialties, 2007. Canadian Pharmacists Association. Webcom Ltd., Toronto, Canada.
6. Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., Gornbein J. The Neuropsychiatric Inventory comprehensive assessment of psychopathology in dementia. Neurology 1994, 44:2308-2314.
7. Doaiswamy P.M., Bieber F., Kaiser L., Krishnan K.R., Reuning-Scherer J., Gulanski B. The Alzheimer's disease assessment scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials. Neurology 1997, 97, 48:1511-1517.
8. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
9. Giri S., Thompson P.D., Taxel P., Contois J.H., Allen R., Ens G., Wu A.H.B., Waters D.D. Oral estrogen improves serum lipids homocysteine and fibrinolysis in elderly men. Atherosclerosis 1998, 137:359-366.
10. Gould E., Woolley C.S., Frankfurt M., McEwen B.S. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J. Neurosci. 1990, 10:1286-1291.
11. Green P.S., Gridley K.E., Simpkins J.W. Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience 1998, 84:7-10.
12. Grundman M., Petersen R.C., Ferris S.H., Thomas R.G., Aisen P.S., Bennett D.A., Foster N.L., Jack C.R., Galasko D.R., Doody R., Kaye J., Sano M., Mohs R., Gauthier S., Kim H.T., Jin S., Schultz A.R., Schafer K., Mulnard R., van Dyck C.H., Mintzer J., Zamrini E.Y., Cahn-Weiner D., Thal L.J. Mild cognitive impairment can be distinguished from Alzheimer's disease and normal aging for clinical trials. Arch. Neurol. 2004, 61:59-66.
13. Halpern D.F. Sex Differences in Cognitive Abilities 2000, Lawrence Erlbaum Assoc, Mahwah, NJ. 3rd edition.
14. Harman S.M., Metter E.J., Tobin J.D., Pearson J., Blackman M.R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J. Clin. Endocrinol. Metab. 2001, 86:724-731.
15. Henderson V.W., Paganini-Hill A., Miller B.L., et al. Estrogen for Alzheimer's disease in women: a randomized, double-blind, placebo-controlled trial. Neurology 2000, 54:295-301.
16. Jaffe A.B., Toran-Allerand C.D., Greengard P., Gandy S.E. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J. Biol. Chem. 1994, 269:13065-13068.
17. Janowsky J.S., Oviatt S.K., Orwoll E.S. Testosterone influences spatial cognition in older men. Behav. Neurosci. 1994, 108:325-332.
18. Kaufman J.M., Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev. 2005, 26:833-876.
19. Luine V.N. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 1985, 89:484-490.
20. McEwen B.S. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 1991, 12:141-147.
21. McEwen B.S. Estrogen action throughout the brain. Recent Prog. Horm. Res. 2002, 57:357-384.
22. McKann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NNCDS-ADRDA work group under the auspices of the Department of Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
23. Mulnard R.A., Cotman C.W., Kawas C.W., van Dyck C.H., Doody M.R., Koss E., Pfeiffer E., Jin S., Gamst A., Grundman G., Thomas R., Thal L.J. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. J. Am. Med. Assoc. 2000, 283:1007-1015. for the Alzheimer's Disease Cooperative Study.
24. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment. Arch. Neurol. 1999, 56:303-308.
25. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., DeKosky S.T. Practice parameter: early detection of dementia: mild cognitive impairment. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:1133-1142.
26. Piaget J., Inhelder B. The Child's Conception of Space 1956, International University Press, New York.
27. Pike C. Estrogen modulates neuronal Bel-xl expression and β-amyloid-induced apoptosis: relevance to Alzheimer's disease. J. Neurochem. 1999, 72:1552-1563.
28. Rey A. L'Examen psychologique dans les cas d'encephalopathie traumatique. Arch. Pathol. 1941, 28:286-340.
29. Schattmann L., Sherwin B.B. Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women. Horm. Behav. 2007, 51:587-596.
30. Schneider L.S., Olin J.T., Doody R.S., Clark C.M., Morris J.C., Reisberg B. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis. Assoc. Disord. 1997, 11(Suppl. 2):S22-32.
31. Sherwin B.B., Henry J. Brain aging modulates the neuroprotective effect of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol. 2008, 29:88-113.
32. The Coronary Drug Project Research Group The Coronary Drug Project. J. Am. Med. Assoc. 1973, 226:652-661.
33. Vandenberg S.G., Kuse A.R. Mental rotations: a group test of three-dimensional spatial visualization. Percept. Motor Skills 1978, 47:599-604.
34. Wechsler D. Wechsler Memory Scale-Revised 1987, The Psychological Corporation, San Antonio, TX.
35. Wolf O.T., Preut R., Hellhammer D.H., Kudielka B.M., Schurmeyer T.H., Kirschbaum C. Testosterone and cognition in elderly men: a single testosterone injection blocks the practice effect in verbal fluency, but has no effect on spatial or verbal memory. Biol. Psychiat. 2000, 47:650-654.